
Four new research priorities have been identified, including synthetic biology, therapeutic development, social determinants of health and implementation science.

Polygenic risk scores demonstrated minimal clinical benefit in predicting long-term coronary heart disease when added to a traditional risk factor model, according to a Northwestern Medicine study.

Northwestern University has been awarded a seven-year grant to study a “pill-in-pocket” strategy to prevent stroke in patients with atrial fibrillation, the most common heart rhythm disorder in adults.

Geography played a role in opioid-involved overdose deaths in the past, but a coming wave may discriminate between rural and urban areas, according to a recent study.

Scientists have uncovered how dopamine connects subregions of the striatum essential for habit formation, according to a Northwestern Medicine study.

A change in function in a mitochondrial protein is associated with gene expression that may promote the development of cancer, according to a recent Northwestern Medicine Study.

In the newly formed Center for Human Immunobiology, teams of interdisciplinary scientists and clinicians will work together to understand the immune system at the molecular level and translate new discoveries into cures for immune-regulated diseases.

Metformin, a common, safe and inexpensive drug for type 2 diabetes, lowered the odds of emergency department visits, hospitalizations or death due to COVID-19 by over 40 percent, according to a new multi-site clinical trial.

A new Northwestern Medicine trial will test whether a telehealth-based intervention that addresses three behavioral risk factors at once can modify cancer patients’ lifestyles to improve their outcomes.

Bigger test panels are better for genetic testing in cardiomyopathy and heart arrhythmias, according to a recent Northwestern Medicine study.